HEADER VIB BINDING PROTEIN 11-MAY-10 3MYU TITLE MYCOPLASMA GENITALIUM MG289 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIGH AFFINITY TRANSPORT SYSTEM PROTEIN P37; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL TRUNCATION (DELTA 1-25); COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOPLASMA GENITALIUM; SOURCE 3 ORGANISM_TAXID: 2097; SOURCE 4 STRAIN: G37; SOURCE 5 GENE: MG289, P37; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLAMSID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET31F1M1 KEYWDS MYCOPLASMA, MYCOPLASMA GENITALIUM, MG289, P37, G37, CYPL, KEYWDS 2 EXTRACYTOPLASMIC, THIAMINE BINDING PROTEIN, LIPOPROTEIN, ATP BINDING KEYWDS 3 CASSETTE TRANSPORTER BINDING PROTEIN, VIB BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.H.SIPPEL,S.K.BOEHLEIN,L.GOVINDASAMY,K.NAMIKI,Y.SATAI,J.G.QUIRIT, AUTHOR 2 M.AGBANDJE-MCKENNA,S.GOODISON,C.J.ROSSER,B.SANKARAN,R.MCKENNA REVDAT 4 06-SEP-23 3MYU 1 REMARK SEQADV HETSYN REVDAT 3 24-JAN-18 3MYU 1 AUTHOR REVDAT 2 19-JAN-11 3MYU 1 JRNL REVDAT 1 20-OCT-10 3MYU 0 JRNL AUTH K.H.SIPPEL,B.VENKATAKRISHNAN,S.K.BOEHLEIN,B.SANKARAN, JRNL AUTH 2 J.G.QUIRIT,L.GOVINDASAMY,M.AGBANDJE-MCKENNA,S.GOODISON, JRNL AUTH 3 C.J.ROSSER,R.MCKENNA JRNL TITL INSIGHTS INTO MYCOPLASMA GENITALIUM METABOLISM REVEALED BY JRNL TITL 2 THE STRUCTURE OF MG289, AN EXTRACYTOPLASMIC THIAMINE BINDING JRNL TITL 3 LIPOPROTEIN. JRNL REF PROTEINS V. 79 528 2011 JRNL REFN ISSN 0887-3585 JRNL PMID 21117240 JRNL DOI 10.1002/PROT.22900 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.H.SIPPEL,S.K.BOEHLEIN,Y.SAKAI,J.G.QUIRIT, REMARK 1 AUTH 2 M.AGBANDJE-MCKENNA,C.J.ROSSER,R.MCKENNA REMARK 1 TITL CLONING, EXPRESSION, PURIFICATION, CRYSTALLIZATION AND REMARK 1 TITL 2 PRELIMINARY X-RAY ANALYSIS OF MYCOPLASMA GENITALIUM PROTEIN REMARK 1 TITL 3 MG289. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.F V. 65 910 2009 REMARK 1 REFN ESSN 1744-3091 REMARK 1 PMID 19724130 REMARK 1 DOI 10.1107/S1744309109030565 REMARK 1 REFERENCE 2 REMARK 1 AUTH K.H.SIPPEL,A.H.ROBBINS,R.REUTZEL,S.K.BOEHLEIN,K.NAMIKI, REMARK 1 AUTH 2 S.GOODISON,M.AGBANDJE-MCKENNA,C.J.ROSSER,R.MCKENNA REMARK 1 TITL STRUCTURAL INSIGHTS INTO THE EXTRACYTOPLASMIC REMARK 1 TITL 2 THIAMINE-BINDING LIPOPROTEIN P37 OF MYCOPLASMA HYORHINIS. REMARK 1 REF J.BACTERIOL. V. 191 2585 2009 REMARK 1 REFN ISSN 0021-9193 REMARK 1 PMID 19233924 REMARK 1 DOI 10.1128/JB.01680-08 REMARK 1 REFERENCE 3 REMARK 1 AUTH K.H.SIPPEL,A.H.ROBBINS,R.REUTZEL,J.DOMSIC,S.K.BOEHLEIN, REMARK 1 AUTH 2 L.GOVINDASAMY,M.AGBANDJE-MCKENNA,C.J.ROSSER,R.MCKENNA REMARK 1 TITL STRUCTURE DETERMINATION OF THE CANCER-ASSOCIATED MYCOPLASMA REMARK 1 TITL 2 HYORHINIS PROTEIN MH-P37. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 64 1172 2008 REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 19020356 REMARK 1 DOI 10.1107/S0907444908030175 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.1_348) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MLHL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.18 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.110 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.9 REMARK 3 NUMBER OF REFLECTIONS : 52800 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.790 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.1951 - 4.2012 0.99 5865 231 0.1865 0.2150 REMARK 3 2 4.2012 - 3.3350 0.99 5612 220 0.2034 0.2299 REMARK 3 3 3.3350 - 2.9135 0.98 5477 217 0.2330 0.2852 REMARK 3 4 2.9135 - 2.6471 0.97 5405 212 0.2465 0.2598 REMARK 3 5 2.6471 - 2.4574 0.95 5262 207 0.2449 0.2698 REMARK 3 6 2.4574 - 2.3125 0.92 5098 202 0.2418 0.2705 REMARK 3 7 2.3125 - 2.1967 0.89 4950 194 0.2433 0.2919 REMARK 3 8 2.1967 - 2.1011 0.87 4800 189 0.2419 0.2986 REMARK 3 9 2.1011 - 2.0202 0.81 4435 175 0.2642 0.3250 REMARK 3 10 2.0202 - 1.9505 0.71 3896 153 0.2818 0.3461 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.95 REMARK 3 K_SOL : 0.32 REMARK 3 B_SOL : 32.81 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.390 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.96 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 5648 REMARK 3 ANGLE : 0.938 7642 REMARK 3 CHIRALITY : 0.061 811 REMARK 3 PLANARITY : 0.004 985 REMARK 3 DIHEDRAL : 14.049 2084 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3MYU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAY-10. REMARK 100 THE DEPOSITION ID IS D_1000059165. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-DEC-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : LIQUID NITROGEN COOLED DUAL REMARK 200 SI(111) CRYSTAL REMARK 200 OPTICS : VERTICALLY COLLIMATING REMARK 200 PREMIRROR, LN2 COOLED DOUBLE- REMARK 200 CRYSTAL SILICON (111) REMARK 200 MONOCHROMATOR, TOROIDAL FOCUSING REMARK 200 M2 MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52800 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 45.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.9 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : 0.07600 REMARK 200 FOR THE DATA SET : 22.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.56000 REMARK 200 R SYM FOR SHELL (I) : 0.56000 REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX (AUTOMR: 1.6.1_348) REMARK 200 STARTING MODEL: PDB ENTRY 3EKI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULFATE, 0.1 M SODIUM REMARK 280 ACETATE TRIHYDRATE PH 4.6 AND 15% PEG 4000 AND HAMPTON SILVER REMARK 280 BULLET BIO CONDITION 49, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.63950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 87.68150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.18300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 87.68150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.63950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.18300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 25 REMARK 465 CYS A 26 REMARK 465 ALA A 27 REMARK 465 THR A 28 REMARK 465 LYS A 29 REMARK 465 SER A 30 REMARK 465 ASP A 31 REMARK 465 GLY A 281 REMARK 465 SER A 282 REMARK 465 LYS A 283 REMARK 465 LYS A 368 REMARK 465 MET B 25 REMARK 465 CYS B 26 REMARK 465 ALA B 27 REMARK 465 THR B 28 REMARK 465 LYS B 29 REMARK 465 SER B 30 REMARK 465 ASP B 31 REMARK 465 GLY B 281 REMARK 465 SER B 282 REMARK 465 LYS B 368 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 42 -127.99 49.70 REMARK 500 ASP A 121 65.24 -154.46 REMARK 500 PHE A 220 -59.24 -156.75 REMARK 500 ALA A 232 -151.41 72.78 REMARK 500 ASN A 234 -6.06 -54.26 REMARK 500 ASP A 245 72.45 -156.85 REMARK 500 LYS A 261 178.68 -59.36 REMARK 500 ASN A 262 -17.54 71.87 REMARK 500 ILE A 290 33.66 -94.10 REMARK 500 VAL A 358 -66.63 -125.56 REMARK 500 PHE B 220 -59.97 -153.66 REMARK 500 ALA B 232 -111.61 51.21 REMARK 500 ASP B 245 59.82 -147.17 REMARK 500 VAL B 358 -60.15 -129.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VIB A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VIB B 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3E78 RELATED DB: PDB REMARK 900 MYCOPLASMA HYORHINIS P37 - HOMOLOG REMARK 900 RELATED ID: 3E79 RELATED DB: PDB REMARK 900 MYCOPLASMA HYORHINIS P37 - HOMOLOG COMPLEXED WITH I3C REMARK 900 RELATED ID: 3EKI RELATED DB: PDB REMARK 900 MYCOPLASMA HYORHINIS P37 - 1.6 ANGSTROM RESOLUTION DBREF 3MYU A 26 368 UNP Q49410 P37_MYCGE 26 368 DBREF 3MYU B 26 368 UNP Q49410 P37_MYCGE 26 368 SEQADV 3MYU MET A 25 UNP Q49410 EXPRESSION TAG SEQADV 3MYU MET B 25 UNP Q49410 EXPRESSION TAG SEQRES 1 A 344 MET CYS ALA THR LYS SER ASP ASN THR LEU ILE PHE ASN SEQRES 2 A 344 ILE SER LEU ASP HIS ASN ALA ASP THR SER ILE GLU LYS SEQRES 3 A 344 PHE PHE THR VAL PHE SER LYS LYS LEU SER GLY LYS LEU SEQRES 4 A 344 ASN LYS LYS ILE ASN VAL ASN PHE ASN ILE VAL ASP ASP SEQRES 5 A 344 SER PHE THR LYS ILE ASN ASN ILE GLN ALA ASN LYS ALA SEQRES 6 A 344 ASP PHE ALA PHE VAL ASN SER GLN ALA ILE ALA SER ASN SEQRES 7 A 344 ASN TRP PHE GLY TYR THR PRO LEU ILE GLN THR LEU THR SEQRES 8 A 344 THR ALA PHE LYS GLU ASP LEU GLU LEU ASP TYR TYR GLU SEQRES 9 A 344 ASP GLY ASN LEU GLN LYS LYS ALA GLU LYS THR ASN LEU SEQRES 10 A 344 LEU PHE LEU SER PRO PRO TYR LYS GLU TRP ASP ASP ILE SEQRES 11 A 344 LYS GLN LYS TRP THR GLY ASN ARG TYR ASP PHE LEU TYR SEQRES 12 A 344 GLU PRO SER LYS LEU VAL SER PHE TYR ARG SER MET ILE SEQRES 13 A 344 LEU ILE THR GLY SER ALA SER GLU ILE THR ALA ILE LYS SEQRES 14 A 344 LYS ALA TRP ASN GLU LYS ASN TRP ASN GLN PHE MET LYS SEQRES 15 A 344 PHE GLY ILE GLY HIS GLY GLN THR ASN SER ALA SER ARG SEQRES 16 A 344 PHE GLU LEU PRO ASP LEU LEU PHE ARG LYS HIS PHE ALA SEQRES 17 A 344 LYS ASN TYR PRO GLY LEU GLN ASN ALA ILE ASN SER ASP SEQRES 18 A 344 PRO ASP LYS PHE ALA VAL VAL ARG GLY ARG GLU ILE GLY SEQRES 19 A 344 ILE ASN LYS ASN ILE LYS ILE VAL PHE ASP ASP ALA ASN SEQRES 20 A 344 SER PHE SER TRP THR GLN ASN ILE LYS GLY SER LYS ARG SEQRES 21 A 344 PRO PHE TYR THR PRO ILE ASP PRO ASN ASP ARG LEU GLU SEQRES 22 A 344 ILE LEU THR TYR SER ASP PRO LEU LEU TYR ASP ILE GLY SEQRES 23 A 344 ILE VAL SER ASN ASN LEU SER ARG ILE TYR GLN LYS ALA SEQRES 24 A 344 ILE GLY GLU ILE PHE ILE GLU LEU ALA GLN SER SER GLU SEQRES 25 A 344 ASP LEU TYR GLY PRO SER ILE GLY TYR ASN GLY TYR LYS SEQRES 26 A 344 MET ILE ASN ASP PHE GLU LYS GLU VAL VAL GLU ILE ILE SEQRES 27 A 344 GLU LYS THR TYR GLY LYS SEQRES 1 B 344 MET CYS ALA THR LYS SER ASP ASN THR LEU ILE PHE ASN SEQRES 2 B 344 ILE SER LEU ASP HIS ASN ALA ASP THR SER ILE GLU LYS SEQRES 3 B 344 PHE PHE THR VAL PHE SER LYS LYS LEU SER GLY LYS LEU SEQRES 4 B 344 ASN LYS LYS ILE ASN VAL ASN PHE ASN ILE VAL ASP ASP SEQRES 5 B 344 SER PHE THR LYS ILE ASN ASN ILE GLN ALA ASN LYS ALA SEQRES 6 B 344 ASP PHE ALA PHE VAL ASN SER GLN ALA ILE ALA SER ASN SEQRES 7 B 344 ASN TRP PHE GLY TYR THR PRO LEU ILE GLN THR LEU THR SEQRES 8 B 344 THR ALA PHE LYS GLU ASP LEU GLU LEU ASP TYR TYR GLU SEQRES 9 B 344 ASP GLY ASN LEU GLN LYS LYS ALA GLU LYS THR ASN LEU SEQRES 10 B 344 LEU PHE LEU SER PRO PRO TYR LYS GLU TRP ASP ASP ILE SEQRES 11 B 344 LYS GLN LYS TRP THR GLY ASN ARG TYR ASP PHE LEU TYR SEQRES 12 B 344 GLU PRO SER LYS LEU VAL SER PHE TYR ARG SER MET ILE SEQRES 13 B 344 LEU ILE THR GLY SER ALA SER GLU ILE THR ALA ILE LYS SEQRES 14 B 344 LYS ALA TRP ASN GLU LYS ASN TRP ASN GLN PHE MET LYS SEQRES 15 B 344 PHE GLY ILE GLY HIS GLY GLN THR ASN SER ALA SER ARG SEQRES 16 B 344 PHE GLU LEU PRO ASP LEU LEU PHE ARG LYS HIS PHE ALA SEQRES 17 B 344 LYS ASN TYR PRO GLY LEU GLN ASN ALA ILE ASN SER ASP SEQRES 18 B 344 PRO ASP LYS PHE ALA VAL VAL ARG GLY ARG GLU ILE GLY SEQRES 19 B 344 ILE ASN LYS ASN ILE LYS ILE VAL PHE ASP ASP ALA ASN SEQRES 20 B 344 SER PHE SER TRP THR GLN ASN ILE LYS GLY SER LYS ARG SEQRES 21 B 344 PRO PHE TYR THR PRO ILE ASP PRO ASN ASP ARG LEU GLU SEQRES 22 B 344 ILE LEU THR TYR SER ASP PRO LEU LEU TYR ASP ILE GLY SEQRES 23 B 344 ILE VAL SER ASN ASN LEU SER ARG ILE TYR GLN LYS ALA SEQRES 24 B 344 ILE GLY GLU ILE PHE ILE GLU LEU ALA GLN SER SER GLU SEQRES 25 B 344 ASP LEU TYR GLY PRO SER ILE GLY TYR ASN GLY TYR LYS SEQRES 26 B 344 MET ILE ASN ASP PHE GLU LYS GLU VAL VAL GLU ILE ILE SEQRES 27 B 344 GLU LYS THR TYR GLY LYS HET VIB A 500 18 HET ACT A 1 4 HET ACT A 2 4 HET VIB B 500 18 HETNAM VIB 3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY- HETNAM 2 VIB ETHYL)-4-METHYL-THIAZOL-3-IUM HETNAM ACT ACETATE ION HETSYN VIB THIAMIN; VITAMIN B1 FORMUL 3 VIB 2(C12 H17 N4 O S 1+) FORMUL 4 ACT 2(C2 H3 O2 1-) FORMUL 7 HOH *247(H2 O) HELIX 1 1 ASN A 43 THR A 46 5 4 HELIX 2 2 SER A 47 ASN A 64 1 18 HELIX 3 3 ASP A 76 ALA A 86 1 11 HELIX 4 4 ASN A 95 ILE A 99 5 5 HELIX 5 5 TYR A 126 ASP A 129 5 4 HELIX 6 6 GLY A 130 SER A 145 1 16 HELIX 7 7 PRO A 147 TRP A 151 5 5 HELIX 8 8 TYR A 163 PHE A 165 5 3 HELIX 9 9 SER A 185 LYS A 199 1 15 HELIX 10 10 ASN A 200 LYS A 206 1 7 HELIX 11 11 PHE A 220 ALA A 232 1 13 HELIX 12 12 GLY A 237 ASP A 245 1 9 HELIX 13 13 ARG A 253 ILE A 257 5 5 HELIX 14 14 ASN A 271 THR A 276 5 6 HELIX 15 15 SER A 317 SER A 334 1 18 HELIX 16 16 TYR A 339 GLY A 344 5 6 HELIX 17 17 ASP A 353 VAL A 358 1 6 HELIX 18 18 VAL A 358 GLY A 367 1 10 HELIX 19 19 ASN B 43 THR B 46 5 4 HELIX 20 20 SER B 47 ASN B 64 1 18 HELIX 21 21 ASP B 76 ALA B 86 1 11 HELIX 22 22 ASN B 95 ILE B 99 5 5 HELIX 23 23 TYR B 126 GLY B 130 5 5 HELIX 24 24 ASN B 131 LEU B 144 1 14 HELIX 25 25 PRO B 147 TRP B 151 5 5 HELIX 26 26 TYR B 163 PHE B 165 5 3 HELIX 27 27 SER B 185 GLU B 198 1 14 HELIX 28 28 ASN B 200 LYS B 206 1 7 HELIX 29 29 PHE B 220 ALA B 232 1 13 HELIX 30 30 LYS B 233 TYR B 235 5 3 HELIX 31 31 GLY B 237 ASP B 245 1 9 HELIX 32 32 ARG B 253 ILE B 257 5 5 HELIX 33 33 ASN B 271 THR B 276 5 6 HELIX 34 34 SER B 317 SER B 334 1 18 HELIX 35 35 TYR B 339 GLY B 344 5 6 HELIX 36 36 ASP B 353 VAL B 358 1 6 HELIX 37 37 VAL B 358 GLY B 367 1 10 SHEET 1 A 6 ASN A 68 ILE A 73 0 SHEET 2 A 6 THR A 33 ILE A 38 1 N LEU A 34 O ASN A 70 SHEET 3 A 6 PHE A 91 VAL A 94 1 O PHE A 91 N ASN A 37 SHEET 4 A 6 ILE A 309 SER A 313 -1 O ILE A 311 N ALA A 92 SHEET 5 A 6 TYR A 107 PHE A 118 -1 N LEU A 110 O GLY A 310 SHEET 6 A 6 TYR A 167 VAL A 173 -1 O VAL A 173 N THR A 115 SHEET 1 B 6 ASN A 68 ILE A 73 0 SHEET 2 B 6 THR A 33 ILE A 38 1 N LEU A 34 O ASN A 70 SHEET 3 B 6 PHE A 91 VAL A 94 1 O PHE A 91 N ASN A 37 SHEET 4 B 6 ILE A 309 SER A 313 -1 O ILE A 311 N ALA A 92 SHEET 5 B 6 TYR A 107 PHE A 118 -1 N LEU A 110 O GLY A 310 SHEET 6 B 6 GLY A 347 MET A 350 -1 O LYS A 349 N GLN A 112 SHEET 1 C 5 PHE A 249 VAL A 251 0 SHEET 2 C 5 ILE A 209 HIS A 211 1 N HIS A 211 O ALA A 250 SHEET 3 C 5 ILE A 265 ASP A 269 1 O ILE A 265 N GLY A 210 SHEET 4 C 5 PHE A 175 GLY A 184 -1 N LEU A 181 O VAL A 266 SHEET 5 C 5 ARG A 295 LEU A 306 -1 O LEU A 299 N ILE A 180 SHEET 1 D 6 ASN B 68 ILE B 73 0 SHEET 2 D 6 THR B 33 ILE B 38 1 N LEU B 34 O ASN B 70 SHEET 3 D 6 PHE B 91 VAL B 94 1 O PHE B 91 N ASN B 37 SHEET 4 D 6 ILE B 309 SER B 313 -1 O ILE B 309 N VAL B 94 SHEET 5 D 6 TYR B 107 PHE B 118 -1 N LEU B 110 O GLY B 310 SHEET 6 D 6 TYR B 167 VAL B 173 -1 O VAL B 173 N THR B 115 SHEET 1 E 6 ASN B 68 ILE B 73 0 SHEET 2 E 6 THR B 33 ILE B 38 1 N LEU B 34 O ASN B 70 SHEET 3 E 6 PHE B 91 VAL B 94 1 O PHE B 91 N ASN B 37 SHEET 4 E 6 ILE B 309 SER B 313 -1 O ILE B 309 N VAL B 94 SHEET 5 E 6 TYR B 107 PHE B 118 -1 N LEU B 110 O GLY B 310 SHEET 6 E 6 GLY B 347 MET B 350 -1 O LYS B 349 N GLN B 112 SHEET 1 F 5 PHE B 249 VAL B 251 0 SHEET 2 F 5 ILE B 209 HIS B 211 1 N HIS B 211 O ALA B 250 SHEET 3 F 5 ILE B 265 ASP B 269 1 O ILE B 265 N GLY B 210 SHEET 4 F 5 PHE B 175 GLY B 184 -1 N MET B 179 O ASP B 268 SHEET 5 F 5 ARG B 295 LEU B 306 -1 O LEU B 299 N ILE B 180 CISPEP 1 SER A 145 PRO A 146 0 -3.87 CISPEP 2 SER B 145 PRO B 146 0 1.79 SITE 1 AC1 10 ASP A 41 HIS A 42 ASN A 161 TYR A 176 SITE 2 AC1 10 TRP A 275 TYR A 307 ASP A 308 ILE A 343 SITE 3 AC1 10 GLY A 344 HOH A 385 SITE 1 AC2 3 ASP A 75 ASP A 76 THR A 79 SITE 1 AC3 5 ASN A 240 HOH A 370 SER B 317 ARG B 318 SITE 2 AC3 5 HOH B 513 SITE 1 AC4 12 ASP B 41 HIS B 42 ASN B 161 TYR B 176 SITE 2 AC4 12 ASP B 269 TRP B 275 TYR B 307 ASP B 308 SITE 3 AC4 12 PRO B 341 ILE B 343 GLY B 344 HOH B 399 CRYST1 49.279 90.366 175.363 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020293 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011066 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005702 0.00000